Tag: ISET 2019
Paclitaxel-releasing devices: An unfolding story
Paclitaxel Timeline:
Meta-analysis finds a higher risk of death in the long term when paclitaxel-coated devices are used in the leg
Without additional long-term...
US FDA continues to investigate paclitaxel devices in the leg
A meta-analysis published in the Journal of the American Heart Association (JAHA) late last year by Konstantinos Katsanos (Patras, Greece) and colleagues, suggesting an...
Promising first-time data indicate human stem cell trial is safe, prompting...
A first-in-human, phase I clinical trial using stem cells to prevent venous stenosis formation in arteriovenous (AV) fistulas yields promising results. Sanjay Misra (Mayo...
Anthony Comerota honoured with career achievement award at ISET
Anthony Comerota, of the Inova Medical Group, Alexandria, USA, received the career achievement award at the 31st International Symposium on Endovascular Therapy (ISET; 27-30...
Chelation therapy surprises experts with positive results in diabetic patients with...
A pilot study of edetate disodium-based chelation in diabetic patients with critical limb ischaemia (CLI) has positive results, leading the study investigators to “cautiously...
ISET Paclitaxel Town Hall: Vast majority of attendees will not change...
The discussion around the use of paclitaxel-coated and eluting devices continues at the 31st International Symposium on Endovascular Therapy (ISET; 27-30 January 2019, Hollywood,...
Why ISET 2019 is a must-attend meeting: Insight from a multidisciplinary...
For three decades, the International Symposium on Endovascular Therapy (ISET) has been providing clinicians with premier endovascular education. In 2019, ISET is investing in...
